Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Sum of short-term and long-term debt obligations
3Y CAGR
+71.8%/yr
Annual compound
5Y CAGR
+2.0%/yr
Recent acceleration
Percentile
P86
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $1.57M | -25.6% |
| 2023 | $2.11M | -18.1% |
| 2022 | $2.58M | +732.6% |
| 2021 | $310000.00 | -58.0% |
| 2020 | $738000.00 | -48.3% |
| 2019 | $1.43M | +443.9% |
| 2018 | $262593.00 | - |
| 2017 | $0.00 | - |
| 2016 | $0.00 | -100.0% |
| 2015 | $265695.00 | - |